Risk Factors for Sever Forms of COVID-19 - A Second Level Moroccan Hospital Experience
PDF

How to Cite

1.
Taoufiq R, Essabbani M, Mouhib NE, Mokahli S, Bougar S, Oubejja NE. Risk Factors for Sever Forms of COVID-19 - A Second Level Moroccan Hospital Experience. ATD [Internet]. 2021 Sep. 28 [cited 2024 Jul. 24];2021. Available from: https://mbmj.org/index.php/atd/article/view/496

Abstract

The new coronavirus (2019-nCoV) has caused the death of more than 1.68 million patients worldwide, including 6,909 deaths registered in Morocco until 12/20/2020. The main objective of this study is to investigate epidemiological, clinical, and paraclinical factors predicting progression to the severity in order to identify patients at risk and adopt strategies for individualized management.
We conduct this observational, descriptive, and analytical study from 01/09/2020 to 25/12/2020, at AL FARABI regional hospital in Oujda. 567 patients were eligible for our study out of 2000 patients who were admitted since our first case on April 2020. Our sample was divided into two groups based on pulse oxygen saturation on admission. We identified 294 as a Severe/Critical case and 273 as a Mild/Moderate form on admission. The mean age was significantly higher in the severe group (63.28 ± 12.4 vs 55.13 ± 17.2). The sex ratio M/F was 0.87. Compared with non-severe cases, severe cases exhibited more comorbidities, including diabetes (60.4% vs 39.6%; P 0.003), and hypertension (63.6% vs 26.4%; P 0.002). Several biological parameters were associated with disease severity in univariate analysis, the most important being lymphopenia, elevated C-reactive protein, and ferritin levels. lymphopenia (OR 3.76; 95% CI, 4.25-9.23), elevated C-reactive protein (OR, 5.7; 95% CI, 3.84-8.48) ferritin levels (OR, 3.6; 95% CI, 1.64-7.89) were significantly associated with severe cases of COVID-19. Mortality is 2.9% for all of our patients; it increases to 4.5% if we consider severe cases only. Identification and evaluation of epidemiological, clinical, and paraclinical parameters are important to identify patients at high risk of SARS-COV2 severity to guide treatment.

https://doi.org/10.15342/atd.2021.496
PDF

References

El Zowalaty ME, Järhult JD. From SARS to COVID-19: A previously unknown SARSrelated coronavirus (SARS-CoV-2) of pandemic potential infecting humans - Call for a One Health approach. One Health. 2020 Feb 24;9:100124. https://doi.org/10.1016/j.onehlt.2020.100124

Gorbalenya AE, Baker SC, Baric R, Groot RJ, Drosten C, Gulyaeva AA, et al. Severe acute respiratory syndrome-related coronavirus: the species and its viruses – a statement of the coronavirus study group. BioRxiv. 2020. https://doi.org/10.1101%2F2020.02.07.937862v1

Ahn DG, Shin HJ, Kim MH, Lee S, Kim HS, Myoung J, et al. Current status of epidemiology, diagnosis, therapeutics, and Vaccines for Novel Coronavirus Disease 2019 (COVID-19). J Microbiol Biotechnol. 2020 Mar 28;30(3):313-324. https://doi.org/10.4014/jmb.2003.03011

Njenga MK, Dawa J, Nanyingi M, Gachohi J, Ngere I, Letko M, et al. Why is There Low Morbidity and Mortality of COVID-19 in Africa? Am J Trop Med Hyg. 2020 Aug;103(2):564-569. https://doi.org/10.4269/ajtmh.20-0474

National Health Commission. Chinese Clinical Guidance For COVID-19 Pneumonia Diagnosis and Treatment- American College of Cardiology (acc.org) (7th version). 2020. [Accessed 2022 Apr 06]. Available from: https://www.acc.org/latest-in-cardiology/articles/2020/03/17/11/22/chinese-clinical-guidance-for-covid-19-pneumonia-diagnosis-and-treatment

Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia inWuhan, China: a descriptive study. Lancet. 2020;395:507–513. https://doi.org/10.1016/S0140-6736(20)30211-7

Chung M, Bernheim A, Mei X, Zhang N, Huang M, Zeng X, et al. CT imaging features of 2019 novel coronavirus (2019-nCoV). Radiology. 2020 Apr;295(1):202-207. https://doi.org/10.1148/radiol.2020200230

Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020 Mar 28;395(10229):1054-1062. https://doi.org/10.1016/s0140-6736(20)30566-3

To KK-W, Tsang OT-Y, Leung W-S, Tam AR, Wu T-C, Lung DC, et al. Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study. Lancet Infect Dis. 2020 May;20(5):565-574.https://doi.org/10.1016/s1473-3099(20)30196-1

Hong KH, Choi JP, Hong SH, Lee J, Kwon JS, Kim SM, et al. Predictors of mortality in Middle East respiratory syndrome (MERS). Thorax. 2018 Mar;73(3):286-289. https://doi.org/10.1136/thoraxjnl-2016-209313

Choi KW, Chau TN, Tsang O, Tso E, Chiu MC, Tong WL, et al. Outcomes and Prognostic Factors in 267 Patients with Severe Acute Respiratory Syndrome in Hong Kong. Ann Intern Med. 2003 Nov 4;139(9):715-23. https://doi.org/10.7326/0003-4819-139-9-200311040-00005

Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia inWuhan, China. JAMA. 2020 Mar 17;323(11):1061-1069. https://doi.org/10.1001/jama.2020.1585

The Lancet. The gendered dimensions of COVID-19. Lancet 2020;395:1168. https://doi.org/10.1016/S0140-6736(20)30823-0

Cai H. Sex difference and smoking predisposition in patients with COVID-19. Lancet Respir Med. 2020 Apr;8(4):e20. https://doi.org/10.1016/s2213-2600(20)30117-x

Zheng Q-L, Duan T, Jin L-P. Single-cell RNA expression profiling of ACE2 and AXL in the human maternal–Fetal interface. Reprod Dev Med. 2020;4:7. https://doi.org/10.4103/2096-2924.278679

Xiaochen Li, Shuyun Xu, Muqing Yu, Ke Wang, Yu Tao, Ying Zhou, et al. Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan. J Allergy Clin Immunol. 2020 Jul;146(1):110-118. https://doi.org/10.1016/j.jaci.2020.04.006

McGurnaghan SJ, Weir A, Bishop J, Kennedy S, Blackbourn LAK, McAllister DA, et al. Risks of and risk factors for COVID-19 disease in people with diabetes: a cohort study of the total population of Scotland. Lancet Diabetes Endocrinol. 2021 Feb;9(2):82-93. https://doi.org/10.1016/s2213-8587(20)30405-8

Li B, Yang J, Zhao F, Zhi L, Wang X, Liu L, et al. Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China. Clin Res Cardiol. 2020 May;109(5):531-538. https://doi.org/10.1007/s00392-020-01626-9

Zhao Q, Meng M, Kumar R, Wu Y, Huang J, Deng Y, et al. Lymphopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A systemic review and meta-analysis. Int J Infect Dis. 2020 Jul;96:131-135. https://doi.org/10.1016/j.ijid.2020.04.086

Li K, Wu J, Wu F, Guo D, Chen L, Fang Z, et al. The Clinical and Chest CT Features Associated With Severe and Critical COVID-19 Pneumonia. Invest Radiol. 2020 Jun;55(6):327-331. https://doi.org/10.1097/rli.0000000000000672

Henry BM, De Oliveira MHS, Benoit S, Plebani M, Lippi G. Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis. Clin Chem Lab Med. 2020 Jun 25;58(7):1021-1028. https://doi.org/10.1515/cclm-2020-0369

Lippi G, Plebani M. Laboratory abnormalities in patients with COVID-2019 infection. Clin Chem Lab Med. 2020 Jun 25;58(7):1131-1134. https://doi.org/10.1515/cclm-2020-0198

Terpos E, Ntanasis-Stathopoulos I, Elalamy I, Kastritis E, Sergentanis TN, PolitouM, et al. Hematological findings and complications of COVID-19. Am J Hematol. 2020 Jul;95(7):834-847. https://doi.org/10.1002/ajh.25829

Zheng Z, Peng F, Xu B, Zhao J, Liu H, Peng J, et al. Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis. J Infect. 2020 Aug;81(2):e16-e25. https://doi.org/10.1016/j.jinf.2020.04.021

Haick AK, Rzepka JP, Brandon E, Balemba OB, Miura TA. Neutrophils are needed for an effective immune response against pulmonary rat coronavirus infection, but also contribute to pathology. J Gen Virol. 2014 Mar;95(Pt 3):578-590. https://doi.org/10.1099/vir.0.061986-0

Didangelos A. COVID-19 hyperinflammation: what about neutrophils? mSphere. 2020 Jun 24;5(3):e00367-20. https://doi.org/10.1128/mSphere.00367-20

Anurag A, Jha PK, Kumar A. Differential white blood cell count in the COVID-19 : A cross-sectional study of 148 patients. Diabetes Metab Syndr. 2020 Nov-Dec;14(6):2099-2102. https://doi.org/10.1016/j.dsx.2020.10.029

Matsumoto H, Kasai T, Sato A, Ishiwata S, Yatsu S, Shitara J, et al. Associa- tion between C-reactive protein levels at hospital admission and long-term mortality in patients with acute decompensated heart failure. Heart Vessels. 2019 Dec;34(12):1961-1968. http://dx.doi.org/10.1007/s00380-019-01435-9

Chalmers S, Khawaja A, Wieruszewski PM, Gajic O, Odeyemi Y. Diagnosis and treatment of acute pulmonary inflammation in critically ill patients: the role of inflammatory biomarkers. World J Crit Care Med. 2019 Sep 11;8(5):59-71. http://dx.doi.org/10.5492/wjccm.v8.i5.59

Yeo C, Kaushal S, Yeo D. Enteric involvement of coronaviruses: is faecal-oral transmission of SARS-CoV-2 possible? Lancet Gastroenterol Hepatol. 2020;5:335-7. https://doi.org/10.1016/s2468-1253(20)30048-0

Velavan TP, Meyer CG. Mild Versus severe COVID-19 : Laboratory markers. Int J Infect Dis. 2020 Jun;95:304-307. https://doi.org/10.1016/j.ijid.2020.04.061

Ruscitti P, Berardicurti O, Di Benedetto P, Cipriani P, Iagnocco A, Shoenfeld Y, et al. Severe COVID-19, another piece in the puzzle of the hyperferritinemic syndrome. An immunomodulatory perspective to alleviate the storm. Front Immunol 2020 ; 11 :1130. https://doi.org/10.3389/fimmu.2020.01130

Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020 Feb 15;395(10223):497-506. https://doi.org/10.1016/s0140-6736(20)30183-5

Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan. China: a retrospective cohort study. Lancet. 2020 Mar 28;395(10229):1054-1062. https://doi.org/10.1016/s0140-6736(20)30566-3

Koo HJ, Lim S, Choe J, Choi SH, Sung H, Do KH. Radiographic and CT features of viral pneumonia. Radiographics. 2018 May-Jun;38(3):719-739. https://doi.org/10.1148/rg.2018170048

Franquet T. Imaging of pulmonary viral pneumonia. Radiology. 2011 Jul;260(1):18-39. https://doi.org/10.1148/radiol.11092149

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright (c) 2021 Taoufiq R et al.

Metrics

Metrics Loading ...